1. Home
  2. OGN vs KFY Comparison

OGN vs KFY Comparison

Compare OGN & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.89

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Korn Ferry

KFY

Korn Ferry

N/A

Current Price

$75.31

Market Cap

3.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
OGN
KFY
Founded
1923
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
OGN
KFY
Price
$13.89
$75.31
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$10.33
★ $91.20
AVG Volume (30 Days)
★ 2.3M
358.2K
Earning Date
10-30-2026
12-08-2026
Dividend Yield
0.58%
★ 2.90%
EPS Growth
N/A
★ 13.48
EPS
★ 1.56
1.32
Revenue
★ $6,216,000,000.00
$1,819,519,000.00
Revenue This Year
N/A
$20.33
Revenue Next Year
$2.07
$10.93
P/E Ratio
★ $8.91
$57.28
Revenue Growth
N/A
★ 12.20
52 Week Low
$5.69
$58.27
52 Week High
$13.90
$87.51

Technical Indicators

Market Signals
Indicator
OGN
KFY
Relative Strength Index (RSI) 64.32 49.23
Support Level $13.72 $70.22
Resistance Level N/A $80.05
Average True Range (ATR) 0.05 1.87
MACD 0.01 -0.08
Stochastic Oscillator 90.63 18.53

Price Performance

Historical Comparison
OGN
KFY

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About KFY Korn Ferry

Korn Ferry is a world'wide consulting firm that powers individual and business performance. The impact it create spans entire organizations, but it always starts with people. The Company has eight reportable segments: Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search Asia Pacific, Executive Search Latin America, Professional Search & Interim and RPO. The company generates majority of revenue from Consulting segment. Consulting helps clients design and implement the talent strategies, organizational structures, and workforce capabilities and rewards to drive growth. The company realigned its organizational structure by geography into three reportable segments: The Americas, EMEA, and Asia Pacific.

Share on Social Networks: